David J. Ecker
David J. Ecker has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Christian Massire
Ibis Biosciences, Carlsbad, California
2 shared publicationsLawrence B. Blyn
Ibis Biosciences, Carlsbad, California
2 shared publicationsMark W. Eshoo
Ibis Biosciences, Carlsbad, California
2 shared publicationsRangarajan Sampath
Ibis Biosciences, Carlsbad, California
2 shared publications- Andrea Endimiani
Institute for Infectious Diseases (IFIK), University of Bern, Bern, Switzerland
1 shared publication Andrea M. Hujer
Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio
1 shared publication
Latest Publications
- 1 May 2009
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 47 (5) , 1436-1442
Rapid Determination of Quinolone Resistance in Acinetobacter spp
In the treatment of serious bacterial infections, the rapid institution of appropriate antimicrobial chemotherapy may be lifesaving. Choosing the correct antibiotic or combination of antibiotics is becoming very important, as multidrug resistance is found in many pathogens. Using a collection of 75 well-characterized multidrug-resistant (MDR) Acinetobacter sp. isolates, we show that PCR followed by electrospray ionization mass spectrometry (PCR/ESI-MS) and base composition analysis of PCR amplification products can quickly and accurately identify quinolone resistance mediated by mutations in the quinolone resistance-determining regions of gyrA and parC , two essential housekeeping genes. Single point mutations detected by PCR/ESI-MS in parC (found in 55/75 of the isolates) and in gyrA (found in 66/75 of the isolates) correlated with susceptibility testing and sequencing. By targeting resistance determinants that are encoded by genes with highly conserved DNA sequences (e.g., gyrA and parC ), we demonstrate that PCR/ESI-MS can provide critical information for resistance determinant identification and can inform therapeutic decision making in the treatment of Acinetobacter sp. infections.
- 1 May 2009
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 47 (5) , 1436-1442
Rapid Determination of Quinolone Resistance in Acinetobacter spp
In the treatment of serious bacterial infections, the rapid institution of appropriate antimicrobial chemotherapy may be lifesaving. Choosing the correct antibiotic or combination of antibiotics is becoming very important, as multidrug resistance is found in many pathogens. Using a collection of 75 well-characterized multidrug-resistant (MDR) Acinetobacter sp. isolates, we show that PCR followed by electrospray ionization mass spectrometry (PCR/ESI-MS) and base composition analysis of PCR amplification products can quickly and accurately identify quinolone resistance mediated by mutations in the quinolone resistance-determining regions of gyrA and parC , two essential housekeeping genes. Single point mutations detected by PCR/ESI-MS in parC (found in 55/75 of the isolates) and in gyrA (found in 66/75 of the isolates) correlated with susceptibility testing and sequencing. By targeting resistance determinants that are encoded by genes with highly conserved DNA sequences (e.g., gyrA and parC ), we demonstrate that PCR/ESI-MS can provide critical information for resistance determinant identification and can inform therapeutic decision making in the treatment of Acinetobacter sp. infections.
- 3 June 2008
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 6 (7) , 553-558
Ibis T5000: a universal biosensor approach for microbiology
We describe a new technology, the Ibis T5000, for the identification of pathogens in clinical and environmental samples. The Ibis T5000 couples nucleic acid amplification to high-performance electrospray ionization mass spectrometry and base-composition analysis. The system enables the identification and quantification of a broad set of pathogens, including all known bacteria, all major groups of pathogenic fungi and the major families of viruses that cause disease in humans and animals, along with the detection of virulence factors and antibiotic resistance markers.
- 3 June 2008
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 6 (7) , 553-558
Ibis T5000: a universal biosensor approach for microbiology
We describe a new technology, the Ibis T5000, for the identification of pathogens in clinical and environmental samples. The Ibis T5000 couples nucleic acid amplification to high-performance electrospray ionization mass spectrometry and base-composition analysis. The system enables the identification and quantification of a broad set of pathogens, including all known bacteria, all major groups of pathogenic fungi and the major families of viruses that cause disease in humans and animals, along with the detection of virulence factors and antibiotic resistance markers.